A long-haired male golden hamster (via Wikipedia & Creative Commons) Earlier this week, a powerful opinion piece, “It Has Come To This: Ignore the CDC,” co-authored by former National Institutes of Health director Harold Varmus, was published in the New York Times. That’s on the science side. On the PR and journalism side, it has… Read More »
[embedded content] [The stream is slated to start at 10 a.m. ET. Please refresh the page if you do not see a player above at that time.] The U.S. House of Representatives Oversight and Reform Committee is holding a hearing Wednesday with current and former executives of three major drug companies on the high cost… Read More »
FRIDAY, May 29, 2020 (HealthDay News) — For men with advanced prostate cancer, a new hormone therapy pill works better than standard injections — and carries a much lower risk of heart attack or stroke, a clinical trial has found. The drug, called relugolix, is not yet approved by the U.S. Food and Drug Administration.… Read More »
Medical researchers perform serology — testing blood samples to find out whether someone already had and recovered from COVID-19 — in Stanford University’s Clinical Virology Lab. Medical researchers perform serology — testing blood samples to find out whether someone already had and recovered from COVID-19 — in Stanford University’s Clinical Virology Lab. Photo: Steve Fisch/Stanford… Read More »